[Emerging infectious diseases--Legionella pneumophila infections].
Saito
A
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007877:Legionnaires' Disease / Q000628:therapy / Q000635:transmission; D010102:Oxygen Inhalation Therapy; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004917:Erythromycin; D012293:Rifampin